Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin-Reference-Cited by-同舟云学术

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin

Published:2016-05-10 Issue:1 Volume:14 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Hall Jason C.,Marlow Laura A.,Mathias Adam C.,Dawson Louis K.,Durham William F.,Meshaw Kenneth A.,Mullin Robert J.,Synnott Aidan J.,Small Daniel L.,Krishna Murli,von Hoff Daniel,Schüler Julia,Hart Steven N.,Couch Fergus J.,Colon-Otero Gerardo,Copland John A.

Funder

NIH/NCI

Grant for rare cancers from Dr. Ellis and Dona Brunton

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-016-0875-z.pdf

Reference64 articles.

1. Holen KD, Klimstra DS, Hummer A, Gonen M, Conlon K, Brennan M, Saltz LB. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 2002;20:4673–8.

2. Zhang N, Lyons S, Lim E, Lassota P. A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging. Clin Cancer Res. 2009;15:4915–24.